MBX Biosciences, Inc. MBX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $45.21M-39.9% | $75.29M-66.3% | $223.13M+461% | $39.78M+33.0% | $29.9M-39.4% | ||
| $394.76M+32.3% | $298.42M+77.1% | $168.55M-9.0% | $185.13M-12.2% | $210.88M-0.9% | ||
| $8.56M+9.3% | $7.83M+34.4% | $5.83M+36.1% | $4.28M+22.8% | $3.49M-32.1% | ||
| $448.54M+17.6% | $381.54M-4.0% | $397.5M+73.4% | $229.19M-6.2% | $244.28M-8.6% | ||
| $3.13M+14.6% | $2.74M+36.5% | $2M+15.8% | $1.73M+14.6% | $1.51M+39.7% | ||
| $453K-7.0% | $487K-6.3% | $520K-5.6% | $551K+505% | $91K-23.5% | ||
| $579K+51.2% | $383K+666% | $50K0.0% | $50K0.0% | $50K0.0% | ||
| $452.7M+17.5% | $385.14M-3.7% | $400.08M+72.8% | $231.52M-5.9% | $245.93M-8.4% | ||
| $6.97M+134% | $2.98M-21.0% | $3.77M-34.6% | $5.76M+35.8% | $4.25M-20.4% | ||
| $7.42M-39.9% | $12.35M+51.7% | $8.14M+39.1% | $5.85M-4.1% | $6.11M+10.1% | ||
| $178K+3.5% | $172K+11.7% | $154K+11.6% | $138K+6.2% | $130K-24.0% | ||
| $14.57M-6.0% | $15.5M+28.5% | $12.06M+2.6% | $11.76M+12.2% | $10.48M-5.2% | ||
| $377K-11.1% | $424K-9.6% | $469K-8.4% | $512K— | —— | ||
| $14.95M-6.1% | $15.92M+27.0% | $12.54M+2.1% | $12.28M+16.9% | $10.5M-5.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $6K0.0% | $6K0.0% | $6K+20.0% | $5K0.0% | $5K0.0% | ||
| $686.35M+15.7% | $593.41M+0.6% | $589.79M+47.4% | $400.02M+0.8% | $396.75M+0.5% | ||
| -$247.99M-10.5% | -$224.48M-10.9% | -$202.41M-12.0% | -$180.8M-12.0% | -$161.39M-17.4% | ||
| -$606K-312% | $286K+85.7% | $154K+1,300% | $11K-79.2% | $53K-3.6% | ||
| —— | —— | —— | —— | —— | ||
| $437.76M+18.6% | $369.22M-4.7% | $387.54M+76.8% | $219.24M-6.9% | $235.42M-8.6% | ||
| $452.7M+17.5% | $385.14M-3.7% | $400.08M+72.8% | $231.52M-5.9% | $245.93M-8.4% | ||
| $394.76M+32.3% | $298.42M+77.1% | $168.55M-9.0% | $185.13M-12.2% | $210.88M-0.9% | ||
| $579K+51.2% | $383K+666% | $50K0.0% | $50K0.0% | $50K0.0% | ||
| $453K-7.0% | $487K-6.3% | $520K-5.6% | $551K+505% | $91K-23.5% | ||
| $453K-7.0% | $487K-6.3% | $520K-5.6% | $551K+505% | $91K-23.5% | ||
| $579K+51.2% | $383K+666% | $50K0.0% | $50K0.0% | $50K0.0% | ||
| $453K-7.0% | $487K-6.3% | $520K-5.6% | $551K+505% | $91K-23.5% | ||
| $579K+51.2% | $383K+666% | $50K0.0% | $50K0.0% | $50K0.0% | ||
| $7.42M-39.9% | $12.35M+51.7% | $8.14M+39.1% | $5.85M-4.1% | $6.11M+10.1% | ||
| $7.42M-39.9% | $12.35M+51.7% | $8.14M+39.1% | $5.85M-4.1% | $6.11M+10.1% | ||
| $555K-6.9% | $596K-4.3% | $623K-4.2% | $650K+400% | $130K-24.0% | ||
| $686.35M+15.7% | $593.41M+0.6% | $589.79M+47.4% | $400.02M+0.8% | $396.75M+0.5% | ||
| $6K0.0% | $6K0.0% | $6K+20.0% | $5K0.0% | $5K0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1K-50.0% | $2K-71.4% | $7K-53.3% | $15K-34.8% | $23K-45.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can MBX Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 30.79 — current assets exceed current liabilities.
- Where does MBX Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.